高级搜索
李雯慧, 吴涛, 陈天荣, 李芸芸, 刘文慧, 田红娟, 周芮. 泽布替尼联合利妥昔单抗、甲氨蝶呤治疗原发中枢弥漫大B细胞淋巴瘤1例报道[J]. 肿瘤防治研究, 2023, 50(8): 830-832. DOI: 10.3971/j.issn.1000-8578.2023.22.1477
引用本文: 李雯慧, 吴涛, 陈天荣, 李芸芸, 刘文慧, 田红娟, 周芮. 泽布替尼联合利妥昔单抗、甲氨蝶呤治疗原发中枢弥漫大B细胞淋巴瘤1例报道[J]. 肿瘤防治研究, 2023, 50(8): 830-832. DOI: 10.3971/j.issn.1000-8578.2023.22.1477
LI Wenhui, WU Tao, CHEN Tianrong, LI Yunyun, LIU Wenhui, TIAN Hongjuan, ZHOU Rui. Zanubrutinib Combined with Rituximab and Methotrexate for Treatment of Primary Central Diffuse Large B-cell Lymphoma: A Case Report[J]. Cancer Research on Prevention and Treatment, 2023, 50(8): 830-832. DOI: 10.3971/j.issn.1000-8578.2023.22.1477
Citation: LI Wenhui, WU Tao, CHEN Tianrong, LI Yunyun, LIU Wenhui, TIAN Hongjuan, ZHOU Rui. Zanubrutinib Combined with Rituximab and Methotrexate for Treatment of Primary Central Diffuse Large B-cell Lymphoma: A Case Report[J]. Cancer Research on Prevention and Treatment, 2023, 50(8): 830-832. DOI: 10.3971/j.issn.1000-8578.2023.22.1477

泽布替尼联合利妥昔单抗、甲氨蝶呤治疗原发中枢弥漫大B细胞淋巴瘤1例报道

Zanubrutinib Combined with Rituximab and Methotrexate for Treatment of Primary Central Diffuse Large B-cell Lymphoma: A Case Report

/

返回文章
返回